XORTX Therapeutics Inc. (XRTX)

CIK 1729214 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for XORTX Therapeutics Inc..

Recent SEC filings

FiledFormAccession number
Sep 10, 20266-K0001171843-26-005981
Sep 9, 20266-K0001185185-26-003895
Sep 4, 20266-K0001185185-26-003845
Aug 28, 20266-K0001171843-26-005782
Aug 17, 20266-K0001171843-26-005562
Aug 4, 20266-K0001171843-26-005158
Jul 29, 20266-K0001171843-26-004972
Jun 15, 20266-K0001171843-26-004112
Jun 12, 20266-K0001171843-26-004098
May 19, 20266-K0001171843-26-003522
May 19, 20266-K0001171843-26-003516
May 15, 2026424B40001104659-26-062030
May 14, 20266-K0001171843-26-003401
May 13, 2026EFFECT9999999995-26-001604
May 8, 20266-K0001104659-26-057982
May 8, 2026POS AM0001104659-26-057834
Apr 23, 2026POS AM0001104659-26-047864
Apr 22, 2026POS AM0001104659-26-046210
Apr 21, 20266-K0001171843-26-002595
Apr 16, 20266-K0001171843-26-002502
Apr 1, 20266-K0001171843-26-002162
Mar 27, 20266-K0001171843-26-001954
Mar 27, 20266-K0001171843-26-001946
Mar 27, 20266-K0001171843-26-001979
Mar 26, 20266-K0001171843-26-001922